DIA421.76+0.12 0.03%
SPX5,967.84-13.03 -0.22%
IXIC19,447.41-98.86 -0.51%

Why Avenue Therapeutics Is Trading Lower By 59%; Here Are 31 Stocks Moving Premarket

Gainers InVivo Therapeutics Holdings Corp. (NASDAQ: NVIV) shares rose 42.3% to $11.36 in pre-market trading after jumping 83% on Thursday.
Benzinga·10/07/2022 11:49:31
Listen to the news

Gainers

  • InVivo Therapeutics Holdings Corp. (NASDAQ:NVIV) shares rose 42.3% to $11.36 in pre-market trading after jumping 83% on Thursday.
  • HEXO Corp. (NASDAQ:HEXO) rose 26.9% to $0.2719 in pre-market trading. Shares of HEXO traded higher by 17% on Thursday after President Biden issued a statement on marijuana reform, which mentioned pardoning 'all prior federal offenses of simple marijuana possession.'
  • Akanda Corp. (NASDAQ:AKAN) rose 20.8% to $0.50 in pre-market trading.
  • Plus Therapeutics, Inc. (NASDAQ:PSTV) rose 19.2% to $0.65 in pre-market trading. JonesTrading initiated coverage on Plus Therapeutics with a Buy rating and announced a price target of $5.
  • Akerna Corp. (NASDAQ:KERN) rose 18.2% to $0.1350 in pre-market trading. The company’s stock jumped around 18% on Thursday after President Biden issued a statement on marijuana reform, which mentioned pardoning 'all prior federal offenses of simple marijuana possession.'
  • Inventiva S.A. (NASDAQ:IVA) rose 15.8% to $4.82 in pre-market trading after gaining around 10% on Thursday.
  • Bright Green Corporation (NASDAQ:BGXX) rose 15.2% to $1.14 in pre-market trading. Bright Green recently reported close of transaction with Alterola Biotech.
  • Ambac Financial Group, Inc (NASDAQ:AMBC) rose 13.4% to $14.51 in pre-market trading. Ambac settled RMBS litigations against Bank Of America for $1.84 billion.
  • Innovative Eyewear, Inc. (NASDAQ:LUCY) rose 12.7% to $1.84 in pre-market trading. The company released October investor presentation on Thursday.
  • The Valens Company Inc. (NASDAQ:VLNS) rose 12.6% to $1.00 in pre-market trading. The Valens Company is expected to issue its Q3 financial results on Thursday, October 13, 2022, before market open.
  • Locafy Limited (NASDAQ:LCFY) rose 11.5% to $0.63 in pre-market trading after jumping around 13% on Thursday. Locafy recently announced it officially launched Brand Boost.
  • Aehr Test Systems (NASDAQ:AEHR) rose 11.1% to $15.41 in pre-market trading as the company posted better-than-expected results for its first quarter on Thursday.
  • cbdMD, Inc. (NASDAQ:YCBD) rose 10.7% to $0.31 in pre-market trading after surging 14% on Thursday.
  • Cyclerion Therapeutics, Inc. (NASDAQ:CYCN) rose 10.5% to $0.6490 in pre-market trading. Cyclerion shares dropped 37% on Thursday after the company announced a mitochondrial disease-focused strategy.
  • Payoneer Global Inc. (NASDAQ:PAYO) rose 8.9% to $7.69 in pre-market trading. Payoneer Global will replace Lantheus Holdings in the S&P SmallCap 600 effective on Wednesday, October 12.
  • Atlas Corp. (NYSE:ATCO) rose 7.3% to $15.07 in pre-market trading. Poseidon Acquisition continued discussions to acquire all common shares of Atlas not controlled by consortium members for $15.50 per share in cash.
  • DraftKings Inc. (NASDAQ:DKNG) rose 7% to $17.17 in pre-market trading on the buzz surrounding a large partnership with Walt Disney’s ESPN.
  • Credit Suisse Group AG (NYSE:CS) rose 6.3% to $4.56 in pre-market trading after reports said the company was planning to buy back $3 billion of its debt as part of its plans to streamline following questions about its financial health.

Don’t forget to check out our premarket coverage here .


Losers

  • Avenue Therapeutics, Inc. (NASDAQ:ATXI) fell 59% to $2.58 in pre-market trading. Avenue Therapeutics priced its 3.6 million unit offering at $3.30 per unit.
  • Argo Blockchain plc (NASDAQ:ARBK) fell 20.4% to $3.32 in pre-market trading. Argo intends to raise around £24 million ($27 million) via proposed subscription with a strategic investor.
  • Green Giant Inc. (NASDAQ:GGE) shares fell 19.2% to $1.52 in pre-market trading after jumping 161% on Thursday.
  • Statera Biopharma, Inc. (NASDAQ:STAB) fell 19% to $0.1850 in pre-market trading. Statera Biopharma said it has completed Fiscal 2021 audit and filed Form 10-K.
  • PureTech Health plc (NASDAQ:PRTC) fell 18.2% to $25.36 in pre-market trading. Puretech Health confirmed that it has exchanged indicative, non-binding proposals with Nektar Therapeutics regarding a possible combination.
  • Bone Biologics Corporation (NASDAQ:BBLG) shares fell 17.7% to $0.7403 in pre-market trading after declining around 12% on Thursday.
  • Pineapple Energy Inc. (NASDAQ:PEGY) fell 16.9% to $3.78 in pre-market trading after jumping around 65% on Thursday.
  • Atlis Motor Vehicles, Inc. (NASDAQ:AMV) shares fell 12.1% to $21.50 in pre-market trading after jumping 95% on Thursday.
  • FingerMotion, Inc. (NASDAQ:FNGR) fell 12.1% to $6.31 in pre-market trading after declining 19% on Thursday.
  • iMedia Brands, Inc. (NASDAQ:IMBI) fell 11.7% to $0.5917 in pre-market trading after dipping 10% on Thursday.
  • Agrify Corporation (NASDAQ:AGFY) shares fell 11.1% to $0.48 in pre-market trading. Agrify issued statement refuting lawsuit from defaulted customer Bud & Mary's Cultivation.
  • Levi Strauss & Co (NYSE:LEVI) fell 5.3% to $15.08 in pre-market trading. Levi Strauss reported upbeat earnings for its third quarter on Thursday, but lowered its full-year profit view.
  • Advanced Micro Devices, Inc. (NASDAQ:AMD) fell 5.3% to $64.28 in pre-market trading after the company lowered its sales guidance for the third quarter.
Risk Disclosure: The content of this page is not an investment advice and does not constitute any offer or solicitation to offer or recommendation of any investment product. It is for general purposes only and does not take into account your individual needs, investment objectives and specific financial circumstances. All investments involve risk and the past performance of securities, or financial products does not guarantee future results or returns. Keep in mind that while diversification may help spread risk it does not assure a profit, or protect against loss, in a down market. There is always the potential of losing money when you invest in securities, or other financial products. Investors should consider their investment objectives and risks carefully before investing. For more details, please refer to risk disclosure.
During the campaign period, US stocks, US stocks short selling, US stock options, Hong Kong stocks, and A-shares trading will maintain at $0 commission, and no subscription/redemption fees for mutual fund transactions. $0 fee offer has a time limit, until further notice. For more information, please visit:  https://www.webull.hk/pricing
Webull Securities Limited is licensed with the Securities and Futures Commission of Hong Kong (CE No. BNG700) for carrying out Type 1 License for Dealing in Securities, Type 2 License for Dealing in Futures Contracts and Type 4 License for Advising on Securities.
Language

English

©2025 Webull Securities Limited. All rights reserved.